NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Huh? Thanks. I’m not certain this confirms it, but it definitely is one source. Although not primary. Somebody might want to call Oncovir or FDA.

Poly ICLC (Hiltonol®): an immune adjuvant targeting the Toll-like receptor 3 (TLR3) pathway; approved for subsets of patients with squamous cell carcinoma — CRI

https://cancerresearch.org/treatment-types/immunomodulators